Stay updated on Branaplam Safety in Early Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Branaplam Safety in Early Huntington's Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a dedicated Locations section including Quebec and Catalonia. Updated to revision v3.3.3 and removed the prior Quebec Locations and Catalonia Locations sections.
    Difference
    0.3%
    Check dated 2025-12-24T11:56:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The Publications section description was updated to indicate that publications are automatically filled in from PubMed, and the revision label was updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:21:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The government funding operating-status notice at the top of the page was removed, and the study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:59:49.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Results have been posted for NCT05111249 (Results First Posted 2024-11-04) and the record was updated on 2025-05-16. The study is terminated due to safety concerns related to potential peripheral neuropathy, with ongoing safety follow-up for participants.
    Difference
    0.4%
    Check dated 2025-11-03T12:44:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-05T17:27:31.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.2%
    Check dated 2025-09-28T10:38:00.000Z thumbnail image

Stay in the know with updates to Branaplam Safety in Early Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.